Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Area of Science:

• Oncology
• Vaccinology
• Epidemiology

Background:

• The Eurogin Roadmap 2015 aims to update practices for human papillomavirus (HPV) infection and disease control.
• Knowledge about HPV is evolving, necessitating a review of current vaccination and screening strategies.
• Two complementary reviews address HPV knowledge and its impact on practice.

Purpose of the Study:

• To review significant findings in HPV vaccine knowledge over the past year.
• To evaluate the impact of new knowledge on HPV infection and disease control.
• To examine evidence regarding HPV-associated head and neck cancers.

Main Methods:

• Literature review of recent findings on HPV vaccines.
• Analysis of data on currently used prophylactic HPV vaccines.
• Inclusion of information on the recently licensed nonavalent HPV vaccine.
• Review of evidence on HPV-associated head and neck cancer.

Main Results:

• Significant findings from the past year have advanced knowledge of existing HPV prophylactic vaccines.
• The nonavalent HPV vaccine represents a recent development in HPV prevention.
• Rapidly evolving evidence exists for HPV-associated head and neck cancer.

Conclusions:

• Updated knowledge of HPV vaccines is crucial for effective infection and disease control.
• The nonavalent vaccine expands options for HPV prevention.
• Further research is needed in HPV-associated head and neck cancers.